OBI-902, targeting TROP2, gains FDA orphan drug status for cholangiocarcinoma, a rare cancer with poor prognosis and limited treatments. Orphan drug designation provides benefits like tax credits and ...
MiBolsilloColombia on MSN
How to use Medicare.gov to find the lowest-cost Part D plan for 2026
Using Medicare.gov can help you find the best Part D plan for 2026, compare costs, and ensure your medications are covered.
You can cut your 2026 drug costs by using Medicare.gov to compare Part D plans based on total annual cost, not just monthly ...
The bill prohibited the FDA from enforcing regulations aimed at increasing traceability of the supply chain, among other ...
The FDA's push for lower-cost medicines looks good on paper, but the patent office under President Trump may be going in the ...
Through substantial leadership turnover and workforce cuts, the FDA has continued to support the advanced therapy sector, ...
The new federal funding law fully restores operations at FDA and USDA through September 30, 2026, and includes food safety ...
The U.S. Food and Drug Administration can approve new personalized treatments for rare and deadly genetic diseases based on ...
US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback